The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The global Wound Care Biologics market was valued at US$ 3940 million in 2023 and is anticipated to reach US$ 8092.5 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
This report aims to provide a comprehensive presentation of the global market for Wound Care Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Care Biologics.
Report Scope
The Wound Care Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wound Care Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wound Care Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Smith and Nephew
- Organogenesis
- MiMedx
- Integra
- Osiris
- Derma Sciences, Inc
- Soluble Systems
- Amnio Technology, LLC
- Medline
- Skye® Biologics
- Alphatec Spine,Inc.
- Pinnacle Transplant Technologies
Segment by Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
Segment by Application
- Acute Wounds
- Chronic Wounds
- Surgical Wounds
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wound Care Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wound Care Biologics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biologic Skin Substitutes
1.2.3 Enzyme Based Formulations
1.2.4 Growth Factors
1.3 Market by Application
1.3.1 Global Wound Care Biologics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Acute Wounds
1.3.3 Chronic Wounds
1.3.4 Surgical Wounds
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Wound Care Biologics Market Perspective (2019-2030)
2.2 Wound Care Biologics Growth Trends by Region
2.2.1 Global Wound Care Biologics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Wound Care Biologics Historic Market Size by Region (2019-2024)
2.2.3 Wound Care Biologics Forecasted Market Size by Region (2025-2030)
2.3 Wound Care Biologics Market Dynamics
2.3.1 Wound Care Biologics Industry Trends
2.3.2 Wound Care Biologics Market Drivers
2.3.3 Wound Care Biologics Market Challenges
2.3.4 Wound Care Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wound Care Biologics Players by Revenue
3.1.1 Global Top Wound Care Biologics Players by Revenue (2019-2024)
3.1.2 Global Wound Care Biologics Revenue Market Share by Players (2019-2024)
3.2 Global Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Wound Care Biologics Revenue
3.4 Global Wound Care Biologics Market Concentration Ratio
3.4.1 Global Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wound Care Biologics Revenue in 2023
3.5 Wound Care Biologics Key Players Head office and Area Served
3.6 Key Players Wound Care Biologics Product Solution and Service
3.7 Date of Enter into Wound Care Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Wound Care Biologics Breakdown Data by Type
4.1 Global Wound Care Biologics Historic Market Size by Type (2019-2024)
4.2 Global Wound Care Biologics Forecasted Market Size by Type (2025-2030)
5 Wound Care Biologics Breakdown Data by Application
5.1 Global Wound Care Biologics Historic Market Size by Application (2019-2024)
5.2 Global Wound Care Biologics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Wound Care Biologics Market Size (2019-2030)
6.2 North America Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Wound Care Biologics Market Size by Country (2019-2024)
6.4 North America Wound Care Biologics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Wound Care Biologics Market Size (2019-2030)
7.2 Europe Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Wound Care Biologics Market Size by Country (2019-2024)
7.4 Europe Wound Care Biologics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Wound Care Biologics Market Size (2019-2030)
8.2 Asia-Pacific Wound Care Biologics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Wound Care Biologics Market Size by Region (2019-2024)
8.4 Asia-Pacific Wound Care Biologics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Wound Care Biologics Market Size (2019-2030)
9.2 Latin America Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Wound Care Biologics Market Size by Country (2019-2024)
9.4 Latin America Wound Care Biologics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Wound Care Biologics Market Size (2019-2030)
10.2 Middle East & Africa Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Wound Care Biologics Market Size by Country (2019-2024)
10.4 Middle East & Africa Wound Care Biologics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Smith and Nephew
11.1.1 Smith and Nephew Company Detail
11.1.2 Smith and Nephew Business Overview
11.1.3 Smith and Nephew Wound Care Biologics Introduction
11.1.4 Smith and Nephew Revenue in Wound Care Biologics Business (2019-2024)
11.1.5 Smith and Nephew Recent Development
11.2 Organogenesis
11.2.1 Organogenesis Company Detail
11.2.2 Organogenesis Business Overview
11.2.3 Organogenesis Wound Care Biologics Introduction
11.2.4 Organogenesis Revenue in Wound Care Biologics Business (2019-2024)
11.2.5 Organogenesis Recent Development
11.3 MiMedx
11.3.1 MiMedx Company Detail
11.3.2 MiMedx Business Overview
11.3.3 MiMedx Wound Care Biologics Introduction
11.3.4 MiMedx Revenue in Wound Care Biologics Business (2019-2024)
11.3.5 MiMedx Recent Development
11.4 Integra
11.4.1 Integra Company Detail
11.4.2 Integra Business Overview
11.4.3 Integra Wound Care Biologics Introduction
11.4.4 Integra Revenue in Wound Care Biologics Business (2019-2024)
11.4.5 Integra Recent Development
11.5 Osiris
11.5.1 Osiris Company Detail
11.5.2 Osiris Business Overview
11.5.3 Osiris Wound Care Biologics Introduction
11.5.4 Osiris Revenue in Wound Care Biologics Business (2019-2024)
11.5.5 Osiris Recent Development
11.6 Derma Sciences, Inc
11.6.1 Derma Sciences, Inc Company Detail
11.6.2 Derma Sciences, Inc Business Overview
11.6.3 Derma Sciences, Inc Wound Care Biologics Introduction
11.6.4 Derma Sciences, Inc Revenue in Wound Care Biologics Business (2019-2024)
11.6.5 Derma Sciences, Inc Recent Development
11.7 Soluble Systems
11.7.1 Soluble Systems Company Detail
11.7.2 Soluble Systems Business Overview
11.7.3 Soluble Systems Wound Care Biologics Introduction
11.7.4 Soluble Systems Revenue in Wound Care Biologics Business (2019-2024)
11.7.5 Soluble Systems Recent Development
11.8 Amnio Technology, LLC
11.8.1 Amnio Technology, LLC Company Detail
11.8.2 Amnio Technology, LLC Business Overview
11.8.3 Amnio Technology, LLC Wound Care Biologics Introduction
11.8.4 Amnio Technology, LLC Revenue in Wound Care Biologics Business (2019-2024)
11.8.5 Amnio Technology, LLC Recent Development
11.9 Medline
11.9.1 Medline Company Detail
11.9.2 Medline Business Overview
11.9.3 Medline Wound Care Biologics Introduction
11.9.4 Medline Revenue in Wound Care Biologics Business (2019-2024)
11.9.5 Medline Recent Development
11.10 Skye® Biologics
11.10.1 Skye® Biologics Company Detail
11.10.2 Skye® Biologics Business Overview
11.10.3 Skye® Biologics Wound Care Biologics Introduction
11.10.4 Skye® Biologics Revenue in Wound Care Biologics Business (2019-2024)
11.10.5 Skye® Biologics Recent Development
11.11 Alphatec Spine,Inc.
11.11.1 Alphatec Spine,Inc. Company Detail
11.11.2 Alphatec Spine,Inc. Business Overview
11.11.3 Alphatec Spine,Inc. Wound Care Biologics Introduction
11.11.4 Alphatec Spine,Inc. Revenue in Wound Care Biologics Business (2019-2024)
11.11.5 Alphatec Spine,Inc. Recent Development
11.12 Pinnacle Transplant Technologies
11.12.1 Pinnacle Transplant Technologies Company Detail
11.12.2 Pinnacle Transplant Technologies Business Overview
11.12.3 Pinnacle Transplant Technologies Wound Care Biologics Introduction
11.12.4 Pinnacle Transplant Technologies Revenue in Wound Care Biologics Business (2019-2024)
11.12.5 Pinnacle Transplant Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
